PUVA and cancer risk: The Swedish follow-up study

British Journal of Dermatology

Volumn 141, Issue 1, 1999, Pages 108-112

  Lindelöf, Bernt ^a   Sigurgeirsson, B ^b   Tegner, E ^c   Larko O ^d   Johannesson, A ^e   Berne, B ^f   Ljunggren, B ^c   Andersson, T ^g   Molin, L ^h   Nylander Lundqvist, E ⁱ   Emtestam, L ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e Swedesh Psoriasis Association   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^h Orebro Hospital   (Sweden)

ⁱ UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; Malignant melanoma; PUVA; Relative risk; Squamous cell carcinoma; Swedish Cancer Registry

Indexed keywords

PSORALEN;

ARTICLE; CANCER RISK; CARCINOGENIC ACTIVITY; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; PRIORITY JOURNAL; PUVA; SKIN CARCINOMA; SKIN DISEASE; SQUAMOUS CELL CARCINOMA;

EID: 0032838965     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02928.x     Document Type: Article

References (39)

1. Stern RS, Thibodeau LA, Kleinerman RA et al. Risks of cutaneous carcinoma in patients treated with oral methoxalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 800-13.
2. Hönigsmann H, Wolff K, Gschnait F et al. Keratoses and nonmelatoma skin tumors in long-term photochemotherapy (PUVA). J Am Acad Dermatol 1980; 3: 406-14.
3. Roenigk HH, Caro WA. Skirt cancer in the PUVA-48 cooperative study. J Am Acad Dermatol 1981; 4: 319-24.
4. Lindskov R. Skin carcinomas and treatment with photochemotherapy (PUVA). Acta Derm Venereol (Stockh) 1993; 63: 223-6.
5. Henseler T, Christophers E. Risk of skin tumors in psoralen- and ultraviolet A-treated patients. Natl Cancer Inst Monogr 1984; 66: 217-19.
6. Reshad H, Challoner F, Pollock DJ et al. Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol 1984; 110: 299-305.
7. Stern RS, Laird N, Melski J et al. Cutaneous squamous cell carcinoma in patients treated with PUVA. N Engl J Med 1984; 310: 1156-61.
8. Eskeleinen A, Halme K, Lassus A et al. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatology 1985; 2: 10-14.
9. Henseler T, Christophers E, Hönigsmann H et al. Skin tumors in the European PUVA study. J Am Acad Dermatol 1987; 16: 108-16.
10. Torinuki W, Tagami H. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy. Goeckerman regimen or both therapies. J Am Acad Dermatol 1988; 18: 1278-81.
11. Stern RS, Lange R and members of the photochemotherapy followup study. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-4.
12. Forman AB, Roenigk HH, Caro WA et al. Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 1989; 125: 515-19.
13. Bruynzeel I, Bergman W, Hartevelt HM et al. High single-dose European PUVA regimen also causes an excess or non-melanoma skin cancer. Br J Immunol 1991; 124: 49-55.
14. Lindelöf B, Sigurgeirsson B, Tegner E et al. PUVA and cancer: A large-scale epidemiological study. Lancet J 1991; 338: 91-3.
15. Chuang T, Heinrich LA, Schultz MD et al. PUVA and skin cancer. J Am Acad Dermatol 1992; 26: 173-7.
16. Olsen JH, Moller H, Frentz C. Malignant tumors in patients with psoriasis. J Am Acad Dermatol 1992; 27: 716-22.
17. Tanew A, Hönigsmann H, Ortel B et al. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. J Am Acad Dermatol 1986; 15: 960-5.
18. Lever LR, Farr PM. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994; 131: 215-19.
19. Maier H, Schemper M, Ortel B et al. Skin tumors in photochemotherapy for psoriasis: A single-center follow-up of 496 patients. Dermatology 1996; 193: 185-91.
20. Frenk E. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy. Dermatologica 1983; 167: 152-4.
21. Marx JL, Auerbach R, Possick P et al. Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A. J Am Acad Dermatol 1983; 9: 904-11.
22. Kemmett D, Reshad H, Baker H. Nodular malignant melanoma and multiple squamous cell carcinomas in patient treated by photochemotherapy for psoriasis. Br Med J 1984; 289: 1498.
23. Johnson J. Melanoma and psoralens and ultraviolet A (letter). J Am Acad Dermatol 1984; 11: 143.
24. Binet O, Bruley C, Beltzer-Garelly E, Cesarini JP. Melanome malin après traitement par rayons ultraviolets A et psoralène (letter). Presse Med 1985; 14: 1842.
25. Gupta AK, Stern RS, Swanson NA et al. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. J Am Acad Dermatol 1988; 19: 67-76.
26. Bergner T, Przybilla B. Malignant melanoma in association with phototherapy. Dermatology J 1992; 84: 59-61.
27. Haciyakupoglu G, Varinli I, Memisoglu H et al. PUVA treatment and choroidal malignant melanoma. Acta Ophthalmol 1993; 71: 846-9.
28. Reseghetti A, Tribbia G, Locati L et al. Cutaneous malignant melanoma appearing during photochemotherapy of mycosis funguides. Dermatology 1994; 189: 75-7.
29. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997; 336: 1041-5.
30. Lindelöf B, Sigurgeirsson B. PUVA treatment in Sweden. Acta Derm Venereol Suppl (Stockh) 1992; 169: 1-6.
31. Mattsson B. Cancer Registration in Sweden: Studies on Completeness and Validity of Incidence and Mortality Registers. PhD Thesis, Karolinska Institute, Stockholm, 1984: 1-33.
32. Sigurgeirsson B. CANEST. A microcomputer program to estimate cancer in a population. Comput Methods Programs Biomed 1991; 35: 193-201.
33. Rhodes AR, Harrist TJ, Momtaz TK. The PUVA-induced pigmented macule: A lentiginous proliferation of large, sometimes cytologically atypical, melanocytes. J Am Acad Dermatol 1983; 9: 17-58.
34. Alcaly J, Bucana C, Kripke ML. Cutaneous pigmented melanocytic tumor in a mouse treated with psoralen plus ultraviolet A radiation. Photodermatol Photoimmunol Photomed 1990; 7: 28-31.
35. Aubin F, Cherrie K, Donawho et al. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells. Cancer Res 1991; 51: 5893-7.
36. Whitmore SE, Morison WL. Melanoma after PUVA therapy for psoriasis (letter). N Engl J Med 1997; 337: 502.
37. Lindelöf B, Sigurgeirsson B, Tegner E et al. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report. Arch Dermatol 1992; 128: 341-4.
38. Lindelöf B, Sigurgeirsson B. PUVA and cancer: A case-control study. Br J Dermatol 1993; 129: 39-41.
39. Lindelöf B, Eklund G, Lidén S et al. The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 1991; 22: 1056-60.